Health and Wellness

Why GLP-1s Might Save More Than They Cost

GLP-1s are making waves in the healthcare world, poised to become one of the most prescribed medications in American history. A recent study by KFF reveals that one in eight

Your Trusted Source for Accurate and Timely Updates!

Our commitment to accuracy, impartiality, and delivering breaking news as it happens has earned us the trust of a vast audience. Stay ahead with real-time updates on the latest events, trends.

Lasted Health and Wellness

A Match Made Indigenous: Celebrating Incoming Native Resident-Physicians

Every year on the third Friday of March, medical students in their final year of medical school eagerly await the

Mass General Brigham to invest $400 million for new cancer institute

The competition in cancer care in Massachusetts took a significant turn as Mass General Brigham announced a $400 million investment

Long Seen As The “Pandemic Of The Poor”, TB Is A Threat To Us All

Defeating Tuberculosis: A Global Health Imperative Despite being preventable and curable, tuberculosis (TB) remains a persistent health threat across the

ME/CFS research, intersex health care, drug confiscations

ME/CFS, also known as myalgic encephalomyelitis/chronic fatigue syndrome, is a debilitating illness that affects millions of people worldwide. The center

Trump Administration’s Attack On DEI Threatens Health For Everyone

The Trump administration's assault on diversity, equity, and inclusion (DEI) initiatives is causing alarm among public health experts regarding the

Scott Gottlieb: Poultry biosecurity, vaccines may be the new normal

These eggs can be redirected for consumption, temporarily increasing the supply of eggs available to consumers. Additionally, regulators could temporarily

How GLP-1 Policy Fits Into Trump’s Greenland Strategy, And 5 Other Health Tech Developments

How does this impact patient care and the trust between patients and their healthcare providers? AI in healthcare has the

DC Diagnosis: Trump’s cuts hit Columbia to AHRQ

The Columbia University research program into myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) has been dealt a severe blow due to recent